Updated on 17 Aug 2026, 11:24 PM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,882.50 | -2.20 | 4,51,664.17 | 39.53 | 5.71 | 0.80 | 0.47 |
| Divi's Laboratories | 8,495.00 | -0.06 | 2,25,515.56 | 78.75 | 12.33 | 0.39 | 0.03 |
| Torrent Pharmaceuticals | 4,895.00 | 1.13 | 1,86,183.41 | 74.49 | 19.68 | 0.78 | 141.16 |
| Cipla | 1,430.00 | -1.38 | 1,15,523.00 | 28.65 | 3.46 | 0.88 | 1.11 |
| Zydus Lifesciences | 1,132.00 | -0.70 | 1,12,917.44 | 20.80 | 4.17 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-08-05 | Quarterly Results & A.G.M. |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-07-28 | Quarterly Results & A.G.M. |
Bharat Parenterals is trading at 1315.60 as on Mon Aug 17 2026 10:20:47. This is -2.51% lower as compared to its previous closing price of 1349.45.
The market capitalization of Bharat Parenterals is 910.90 Cr as on Mon Aug 17 2026 10:20:47.
The 52 wk high for Bharat Parenterals is 1559.90 whereas the 52 wk low is 880.25
Bharat Parenterals can be analyzed on the following key metrics -
Bharat Parenterals reported a net profit of - Cr in -.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.